Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency

Development of this COS illustrates a patient-centered approach for clinical trial readiness for CTD and GAMT that if utilized will make clinical trial results comparable, minimize bias in clinical trial outcome selection, and promote efficient use of resources.